Black Mamba KSM-66 Ashwagandha

Description Black Mamba KSM-66 Ashwagandha Introducing Black Mamba KSM-66 Ashwagandha. This product is known for its ability to support stress reduction, cognitive function, and physical performance. It has also been shown to help support healthy immune function, promote healthy sleep patterns, and improve overall energy levels. Suggested Use Our KSM-66 Ashwagandha is 1200mg per serving. Take 2 capsules per day. KSM-66 Ashwagandha is a branded, full-spectrum extract, with the highest concentration of all major root only extracts available on the market today. It is produced using a unique proprietary extraction process, based on “Green Chemistry” principles, without using alcohol or any other chemical solvent. In 24 double blind, randomized placebo controlled clinical trials KSM-66 Ashwagandha has been clinically proven to: Reduce stress, stress-related food cravings and enhance quality of sleep Enhance memory and cognition Increase endurance, strength, and immune function Improve sexual function in both men and women, and testosterone in men KSM-66 STRICTLY AVOIDS THE USE OF LEAVES KSM-66 uses only the roots of the ashwagandha plant with absolutely no addition of leaves. Our financial advisors point out that our profits would be far higher if we replaced roots with leaves, given that the price of leaves is often less than 1/15th the price of roots. Despite that, our founders have stood by their basic principle to use roots only. Customers are often curious to know why. To understand our rationale, it helps to know a little about our company. We are a family-owned business founded with the sole mission of supplying the absolute best quality ashwagandha. To be faithful to our mission, we feel it necessary to stay close to mainstream practice and modern scientific evidence. Both in independent clinical trials and in thousands of years of traditional use, the root is the part of the plant that is used predominantly for adaptogenic benefits and internal ingestion. The primary use of leaves traditionally was for topical treatments on the skin for conditions like burns or carbuncles, not internal consumption. The use of the roots is on significantly better scientific foundation in terms of human clinical evidence and period of observation than the use of leaves. Ashwagandha root consumption has been much heavier with much greater opportunity to observe its safety than ashwagandha leaf consumption. The predominant majority of published clinical trials today are on the root and not the leaf. The coverage of ashwagandha in reference works like the pharmacopoeias is only on the root. These reference works are the United States Pharmacopoeia, the British Pharmacopoeia, the Indian Pharmacopoeia, the Ayurvedic Pharmacopoeia, Indian Materia Medica, the Health Canada monograph and the W.H.O. monograph. The leaf is in fact not even mentioned in any of them for therapeutic use and ingestion. Regulatory bodies in some European countries allow only the root of ashwagandha plant and not the leaves. Additionally find out more about Black Mamba here. Also check out our Special Offers here.